Valuation: Medios AG

Market Cap 296M 338M 273M 255M 480M 31.98B 489M 3.28B 1.27B 15.78B 1.27B 1.24B 54.97B P/E 2026 *
10.9x
P/E 2027 * 8.69x
Enterprise Value 372M 425M 343M 320M 604M 40.19B 614M 4.12B 1.6B 19.83B 1.6B 1.56B 69.09B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.16x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day-0.17%
1 week-1.31%
Current month-0.17%
1 month-11.32%
3 months-3.21%
6 months-17.85%
Current year-16.71%
1 week 11.98
Extreme 11.98
12.38
1 month 11.8
Extreme 11.8
13.64
Current year 11.64
Extreme 11.64
17.44
1 year 11.64
Extreme 11.64
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap.
02-04Sell

Chief Executive Officer

13,638 0.0535%
01-22Buy

Executive/Senior Manager

4,000 0.0157%
19/08/24Buy

Executive/Senior Manager

10,000 0.0392%
Change 5-day change 1-year change 3-year change Capi.($)
-0.17%-1.31%-2.11%-24.62% 338M
-2.48%+8.34%+53.87%+155.75% 1,070B
-1.76%+6.23%+66.27%+53.44% 611B
-1.05%+7.19%+35.57%+86.77% 445B
-2.17%+4.18%+31.11%+23.88% 329B
+0.02%+1.32%+35.49%+35.86% 290B
-0.79%+1.13%+28.44%+42.01% 287B
+0.79%+1.88%-27.59%-41.36% 213B
+0.44%+4.35%+29.69%+63.10% 195B
+0.01%+1.03%+13.95%+63.93% 157B
Average -0.15%+4.54%+26.47%+45.88% 359.66B
Weighted average by Cap. -0.21%+6.67%+40.24%+78.32%

Financials

2026 *2027 *
Net sales 2.08B 2.38B 1.92B 1.79B 3.38B 225B 3.44B 23.05B 8.95B 111B 8.93B 8.73B 387B 2.14B 2.44B 1.97B 1.84B 3.47B 231B 3.53B 23.67B 9.19B 114B 9.18B 8.97B 397B
Net income 27.56M 31.48M 25.44M 23.73M 44.71M 2.98B 45.51M 305M 118M 1.47B 118M 116M 5.12B 34.36M 39.25M 31.72M 29.58M 55.74M 3.71B 56.74M 380M 148M 1.83B 147M 144M 6.38B
Net Debt 76M 86.83M 70.16M 65.44M 123M 8.21B 126M 842M 327M 4.05B 326M 319M 14.11B 40.72M 46.53M 37.59M 35.07M 66.07M 4.4B 67.25M 451M 175M 2.17B 175M 171M 7.56B
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
993
Date Price Change Volume
01/07/26 12.06 -0.17% 9,008
30/06/26 €12.08 -0.33% 26,862
29/06/26 €12.12 +0.33% 47,058
26/06/26 €12.08 -0.17% 18,791
25/06/26 €12.10 -0.98% 20,352
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.08EUR
Average target price
23.00EUR
Spread / Average Target
+90.40%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILM1 Stock